Immune Reconstitution as a Determinant of Adverse Effects to New Antiretroviral Therapy in Persons With Advanced HIV Infection

NCT00885664 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Truvada (tenofovir/emtricitabine)
DRUG: Kaletra (lopinavir/ritonavir)

Sponsor

University of Cincinnati

Collaborators

[object Object]
[object Object]